Chromoblastomycosis

Signs and symptoms

The initial trauma causing the infection is often forgotten or not noticed. The infection builds at the site over the years, and a small red papule (skin elevation) appears. The lesion is usually not painful, with few, if any, symptoms. Patients rarely seek medical care at this point.

Several complications may occur. Usually, the infection slowly spreads to the surrounding tissue while remaining localized to the area around the original wound. However, sometimes the fungi may spread through the blood vessels or lymph vessels, producing metastatic lesions at distant sites. Another possibility is secondary infection with bacteria. This may lead to lymph stasis (obstruction of the lymph vessels) and elephantiasis. The nodules may become ulcerated, or multiple nodules may grow and coalesce, affecting a large area of a limb.

Cause

Chromoblastomycosis is believed to originate in minor trauma to the skin, usually from vegetative material such as thorns or splinters; this trauma implants the fungus in the subcutaneous tissue. In many cases, the patient will not notice or remember the initial trauma, as symptoms often do not appear for years. The fungi most commonly observed to cause chromoblastomycosis are:

• Fonsecaea pedrosoi
• Cladophialophora bantiana causes both cutaneous chromoblastomycosis and systemic phaeohyphomycosis
• Phialophora verrucosa
• Cladophialophora carrionii
• Fonsecaea compacta

Mechanism

Over months to years, an erythematous papule appears at the site of inoculation. Although the mycosis slowly spreads, it usually remains localized to the skin and subcutaneous tissue. Hematogenous and/or lymphatic spread may occur. Multiple nodules may appear on the same limb, sometimes coalescing into a large plaque. Secondary bacterial infection may occur, sometimes inducing lymphatic obstruction. The central portion of the lesion may heal, producing a scar, or it may ulcerate.

Diagnosis

The most informative test is to scrape the lesion and add potassium hydroxide (KOH), then examine it under a microscope. (KOH scrapings are commonly used to examine fungal infections.) The pathognomonic finding is observing medlar bodies (also called muriform bodies or sclerotic cells). Scrapings from the lesion can also be cultured to identify the organism involved. Blood tests and imaging studies are not commonly used. On histology, chromoblastomycosis manifests as pigmented yeasts resembling "copper pennies". Special stains, such as periodic acid Schiff and Gömöri methenamine silver, can be used to demonstrate the fungal organisms if needed.

Prevention

No preventive measure is known. At least one study found a correlation between walking barefoot in endemic areas and the occurrence of chromoblastomycosis on the foot.

Treatment

Chromoblastomycosis is very difficult to cure. The primary treatments of choice are:

• Itraconazole, an antifungal azole, is given orally, with or without flucytosine.
• Alternatively, cryosurgery with liquid nitrogen has also been shown to be effective.

Other treatment options are the antifungal drug terbinafine, another antifungal azole posaconazole, and heat therapy.

Antibiotics may be used to treat bacterial superinfections.

Amphotericin B has also been used.

Photodynamic therapy is a newer type of therapy used to treat Chromoblastomycosis.

Prognosis

The prognosis for chromoblastomycosis is very good for small lesions. Severe cases are difficult to cure, although the prognosis is still good. The primary complications are ulceration, lymphedema, and secondary bacterial infection. A few cases of malignant transformation to squamous cell carcinoma have been reported. Chromoblastomycosis is very rarely fatal.

Epidemiology

Chromoblastomycosis occurs globally, most commonly in rural areas in tropical or subtropical climates.

It is most common in rural areas between approximately 30°N and 30°S latitude. Over two-thirds of patients are male, usually between the ages of 30 and 50. A correlation with HLA-A29 suggests genetic factors may play a role, as well.

Social and cultural

Chromoblastomycosis is considered a neglected tropical disease, affects mainly people living in poverty, and causes considerable morbidity, stigma, and discrimination.

References

References

1. Rapini, Ronald P.. (2007). "Dermatology: 2-Volume Set". Mosby.
2. {{DorlandsDict. two/000021022. chromoblastomycosis
3. (2007). "Chromoblastomycosis". Clin. Dermatol..
4. "Chromoblastomycosis {{!}} Genetic and Rare Diseases Information Center (GARD) – an NCATS Program".
5. "Chromoblastomycosis {{!}} DermNet New Zealand".
6. (August 2021). "The global burden of chromoblastomycosis". PLOS Neglected Tropical Diseases.
7. Ran Yuping. (2016). "Modern Electron Microscopy in Physical and Life Sciences". InTech.
8. (2001). "Chromoblastomycosis: clinical and mycologic experience of 51 cases". Mycoses.
9. (March 2007). "Rapid identification of Fonsecaea by duplex polymerase chain reaction in isolates from patients with chromoblastomycosis". Diagn. Microbiol. Infect. Dis..
10. (March 2005). "A case of chromoblastomycosis with an unusual clinical manifestation caused by Phialophora verrucosa on an unexposed area: treatment with a combination of amphotericin B and 5-flucytosine". Br. J. Dermatol..
11. Attapattu MC. (1997). "Chromoblastomycosis--a clinical and mycological study of 71 cases from Sri Lanka". Mycopathologia.
12. (February 2005). "Treatment of chromoblastomycosis with terbinafine: experience with four cases". J Dermatolog Treat.
13. (March 2008). "Extensive chromoblastomycosis caused by Fonsecaea pedrosoi successfully treated with a combination of amphotericin B and itraconazole". Med. Mycol..
14. (2013-06-01). "Challenges in the Therapy of Chromoblastomycosis". Mycopathologia.
15. (January 2017). "Chromoblastomycosis". Clinical Microbiology Reviews.